Barclays

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
9,146
Total Value
175908309
Accession Number
0000312069-25-000408
Form Type
13F-HR
Manager Name
Barclays
Data Enrichment
89% identified
8,179 identified967 unidentified

Holdings

9,146 positions • $175.9M total value
Manager:
Search and click to pin securities to the top
Safety Shot, Inc.
Shares:1
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
TriSalus Life Sciences, Inc.
Shares:32
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Fathom Holdings Inc.
Shares:72
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Rafael Holdings, Inc.
Shares:1
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
G86302117
Shares:238
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
GameSquare Holdings, Inc.
Shares:85
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Ainos, Inc.
Shares:215
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Liberty Latin America Ltd.
Shares:39
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
SANGAMO THERAPEUTICS, INC
Shares:1
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Alset Inc.
Shares:5
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
AmpliTech Group, Inc.
Shares:4
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
AYTU BIOPHARMA, INC
Shares:1
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Ocean Power Technologies, Inc.
Shares:637
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Beneficient
Shares:5
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
46435U853
Shares:10
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
LISATA THERAPEUTICS, INC.
Shares:4
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Channel Therapeutics Corp
Shares:54
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
16307X202
Shares:301
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
19207A207
Shares:3
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Direct Digital Holdings, Inc.
Shares:4
Value:$0
% of Portfolio:0.0% ($0/$175.9M)